JAG1 and neoplasm: Reedijk and colleague [71] observed that patients with tumours expressing high levels of JAG1 or Notch1 had a significantly poorer overall survival compared with patients expressing low levels of these genes, and moreover, a synergistic effect of high-level JAG1 and high-level Notch1 coexpression on overall survival was observed.